EurekAlert! -
21 Nov 2017 07:00
(University of Illinois at Chicago) Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.
Share this Article